122 related articles for article (PubMed ID: 37462216)
21. Synthesis, characterization, and biological evaluation of some novel Schiff bases as potential metabolic enzyme inhibitors.
Çakmak R; Başaran E; Şentürk M
Arch Pharm (Weinheim); 2022 Apr; 355(4):e2100430. PubMed ID: 34994010
[TBL] [Abstract][Full Text] [Related]
22. Carbonic anhydrase inhibitory activity of phthalimide-capped benzene sulphonamide derivatives.
Shilkar D; Mohd Siddique MU; Bua S; Yasmin S; Patil M; Timiri AK; Supuran CT; Jayaprakash V
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2235089. PubMed ID: 37439360
[TBL] [Abstract][Full Text] [Related]
23. Inhibition Profiles of Some Symmetric Sulfamides Derived from Phenethylamines on Human Carbonic Anhydrase I, and II Isoenzymes.
Topal F; Aksu K; Gulcin I; Tümer F; Goksu S
Chem Biodivers; 2021 Oct; 18(10):e2100422. PubMed ID: 34387019
[TBL] [Abstract][Full Text] [Related]
24. Novel 1,3,5-Triazinyl Aminobenzenesulfonamides Incorporating Aminoalcohol, Aminochalcone and Aminostilbene Structural Motifs as Potent Anti-VRE Agents, and Carbonic Anhydrases I, II, VII, IX, and XII Inhibitors.
Havránková E; Garaj V; Mascaretti Š; Angeli A; Soldánová Z; Kemka M; Motyčka J; Brázdová M; Csöllei J; Jampílek J; Supuran CT
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008657
[TBL] [Abstract][Full Text] [Related]
25. N-Quinary heterocycle-4-sulphamoylbenzamides exert anti-hypoxic effects as dual inhibitors of carbonic anhydrases I/II.
Yang C; Wang J; Cheng Y; Yang X; Feng Y; Zhuang X; Li Z; Zhao W; Zhang J; Sun X; He X
Bioorg Chem; 2020 Jul; 100():103931. PubMed ID: 32450385
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of sulfonamide-bearing thiazole as carbonic anhydrase isoforms hCA I and hCA II.
Kılıcaslan S; Arslan M; Ruya Z; Bilen Ç; Ergün A; Gençer N; Arslan O
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1300-5. PubMed ID: 26744900
[TBL] [Abstract][Full Text] [Related]
27. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and comparative carbonic anhydrase inhibition of new Schiff's bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds.
El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; Alanazi MM; AlSaif NA; Al-Suwaidan IA; Hefnawy MM; Supuran CT
Bioorg Chem; 2019 Nov; 92():103225. PubMed ID: 31493707
[TBL] [Abstract][Full Text] [Related]
29. Some phenolic natural compounds as carbonic anhydrase inhibitors: An in vitro and in silico study.
Aggul AG; Uzun N; Kuzu M; Taslimi P; Gulcin I
Arch Pharm (Weinheim); 2022 Jun; 355(6):e2100476. PubMed ID: 35306678
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of new 7-amino-3,4-dihydroquinolin-2(1H)-one-peptide derivatives and their carbonic anhydrase enzyme inhibition, antioxidant, and cytotoxic activities.
Küçükbay H; Gönül Z; Küçükbay FZ; Tekin Z; Angeli A; Bartolucci G; Supuran CT; Tatlıcı E; Apohan E; Yeşilada Ö
Arch Pharm (Weinheim); 2021 Nov; 354(11):e2100122. PubMed ID: 34313324
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and Characterization of Novel 1,3-Diaryltriazene-Substituted Sulfaguanidine Derivatives as Selective Carbonic Anhydrase Inhibitors: Biological Evaluation, in Silico ADME/T and Molecular Docking Study.
Akocak S; Lolak N; Duran HE; Işık M; Türkeş C; Durgun M; Beydemir Ş
Chem Biodivers; 2023 Aug; 20(8):e202300611. PubMed ID: 37470688
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Carbonic Anhydrase Inhibition of Tetrabromo Chalcone Derivatives.
Kocyigit UM; Budak Y; Eligüzel F; Taslimi P; Kılıç D; Gulçin İ; Ceylan M
Arch Pharm (Weinheim); 2017 Dec; 350(12):. PubMed ID: 29134667
[TBL] [Abstract][Full Text] [Related]
33. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
Soliman AM; Ghorab MM; Bua S; Supuran CT
Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
[TBL] [Abstract][Full Text] [Related]
34. In vitro inhibitory effects of some acetophenone derivatives on some metabolic enzymes and molecular docking.
Taslimi P
Arch Pharm (Weinheim); 2020 Nov; 353(11):e2000210. PubMed ID: 32876951
[TBL] [Abstract][Full Text] [Related]
35. The human carbonic anhydrase isoenzymes I and II (hCA I and II) inhibition effects of trimethoxyindane derivatives.
Taslimi P; Gulcin I; Ozgeris B; Goksu S; Tumer F; Alwasel SH; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(1):152-7. PubMed ID: 25697270
[TBL] [Abstract][Full Text] [Related]
36. Carbonic Anhydrase Inhibition Activities of Schiff's Bases Based on Quinazoline-Linked Benzenesulfonamide.
El-Azab AS; Abdel-Aziz AA; Ghabbour HA; Bua S; Nocentini A; Alkahtani HM; Alsaif NA; Al-Agamy MHM; Supuran CT
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431826
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, enzyme inhibition, and molecular docking studies of a novel chalcone series bearing benzothiazole scaffold.
Musatat AB; Atahan A; Ergün A; Çıkrıkcı K; Gençer N; Arslan O; Zengin M
Biotechnol Appl Biochem; 2023 Jun; 70(3):1357-1370. PubMed ID: 36722438
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors.
Askin S; Tahtaci H; Türkeş C; Demir Y; Ece A; Akalın Çiftçi G; Beydemir Ş
Bioorg Chem; 2021 Aug; 113():105009. PubMed ID: 34052739
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of benzamide derivatives with thiourea-substituted benzenesulfonamides as carbonic anhydrase inhibitors.
Tugrak M; Gul HI; Demir Y; Gulcin I
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000230. PubMed ID: 33043495
[TBL] [Abstract][Full Text] [Related]
40. New halogenated chalcones with cytotoxic and carbonic anhydrase inhibitory properties: 6-(3-Halogenated phenyl-2-propen-1-oyl)-2(3H)-benzoxazolones.
Bilginer S; Gul HI; Erdal FS; Sakagami H; Gulcin I
Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900384. PubMed ID: 32285546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
